| ARTV |
Artiva Biotherapeutics, Inc. |
18 Feb 2026 |
1 |
$0 |
4 |
Director |
19 Feb 2026, 21:50 |
| ARTV |
Artiva Biotherapeutics, Inc. |
18 Feb 2026 |
0 |
$0 |
3 |
Director |
19 Feb 2026, 21:41 |
| ABBV |
AbbVie Inc. |
25 Apr 2023 |
3 |
-$1,011,450 |
4 |
SVP, US COMMERCIAL OPERATIONS |
27 Apr 2023, 17:00 |
| ABBV |
AbbVie Inc. |
17 Apr 2023 |
2 |
-$1,212,338 |
4 |
SVP, US COMMERCIAL OPERATIONS |
19 Apr 2023, 17:00 |
| ABBV |
AbbVie Inc. |
03 Apr 2023 |
3 |
-$2,400,770 |
4 |
SVP, US COMMERCIAL OPERATIONS |
05 Apr 2023, 17:00 |
| ABBV |
AbbVie Inc. |
28 Feb 2023 |
4 |
-$5,387,923 |
4 |
SVP, US COMMERCIAL OPERATIONS |
02 Mar 2023, 16:07 |
| ABBV |
AbbVie Inc. |
16 Feb 2023 |
9 |
-$2,314,119 |
4 |
SVP, US COMMERCIAL OPERATIONS |
21 Feb 2023, 17:12 |
| ABBV |
AbbVie Inc. |
25 Feb 2022 |
4 |
-$2,625,099 |
4 |
SVP, US Commercial Operations |
01 Mar 2022, 17:11 |
| ABBV |
AbbVie Inc. |
17 Feb 2022 |
6 |
$0 |
4 |
SVP, US Commercial Operations |
22 Feb 2022, 16:42 |
| ABBV |
AbbVie Inc. |
10 Dec 2021 |
3 |
-$1,450,498 |
4 |
SVP, US Commercial Operations |
14 Dec 2021, 16:01 |
| ABBV |
AbbVie Inc. |
23 Aug 2021 |
4 |
-$759,931 |
4 |
SVP, US Commercial Operations |
25 Aug 2021, 18:08 |